Date published: 2026-2-14

1-800-457-3801

SCBT Portrait Logo
Seach Input

CAMTA1 Inhibitors

CAMTA1 Inhibitors encompasses a range of compounds that indirectly modulate the activity of CAMTA1 through interference in calcium signaling pathways and calmodulin interactions. This category predominantly includes calcium channel blockers and calmodulin antagonists, each influencing CAMTA1 function via distinct mechanisms within the cellular environment. Calcium channel blockers, such as Verapamil, and others, primarily function by inhibiting the influx of calcium ions through voltage-gated calcium channels. The reduction of intracellular calcium levels elicited by these compounds is crucial, given the dependency of CAMTA1 on calcium-mediated signaling for its regulatory activities. By diminishing calcium availability, these inhibitors indirectly affect the activation of calmodulin, a key calcium-binding messenger protein. This action results in a downstream impact on CAMTA1, considering its regulation by calmodulin-dependent mechanisms. Such a mode of action highlights the intricate interplay between calcium dynamics and transcriptional regulation mediated by proteins like CAMTA1.

Trifluoperazine, and Chlorpromazine, exhibit a different mechanism of action. These chemicals bind to calmodulin, thereby inhibiting its interaction with target proteins, potentially including CAMTA1. This blockade disrupts calmodulin-dependent signaling pathways, leading to an indirect modulation of CAMTA1's transcriptional activity. Additional members of this chemical class, such as Thapsigargin and Dantrolene, contribute to the regulation of intracellular calcium by targeting the storage and release mechanisms within cells. Thapsigargin, for instance, is a non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), affecting the sequestration of calcium in cellular storage compartments. Dantrolene interferes with the release of calcium from the sarcoplasmic reticulum. These actions collectively represent a multifaceted approach to regulating CAMTA1 activity, emphasizing the complexity of cellular signaling networks and the intricate role of calcium as a ubiquitous secondary messenger in numerous cellular processes.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

W-7

61714-27-0sc-201501
sc-201501A
sc-201501B
50 mg
100 mg
1 g
$166.00
$306.00
$1675.00
18
(1)

W-7 Hydrochloride is a calmodulin antagonist that disrupts calmodulin-dependent signaling pathways, potentially affecting CAMTA1 activity indirectly.

Chlorpromazine

50-53-3sc-357313
sc-357313A
5 g
25 g
$61.00
$110.00
21
(1)

Chlorpromazine, a phenothiazine antipsychotic, has been shown to bind to calmodulin, potentially modulating CAMTA1 activity indirectly through calmodulin pathways.

Thapsigargin

67526-95-8sc-24017
sc-24017A
1 mg
5 mg
$136.00
$446.00
114
(2)

Thapsigargin is a non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), affecting calcium homeostasis, which could indirectly impact CAMTA1 function.

Verapamil

52-53-9sc-507373
1 g
$374.00
(0)

Verapamil is a calcium channel blocker that could indirectly affect CAMTA1 activity by altering intracellular calcium levels.

Nimodipine

66085-59-4sc-201464
sc-201464A
100 mg
1 g
$61.00
$307.00
2
(1)

Nimodipine, a dihydropyridine calcium channel blocker, potentially affects CAMTA1 by altering calcium dynamics within cells.

Amlodipine

88150-42-9sc-200195
sc-200195A
100 mg
1 g
$74.00
$166.00
2
(1)

Amlodipine, a calcium channel antagonist, could indirectly modulate CAMTA1 activity through its effects on calcium signaling.

Dantrolene

7261-97-4sc-500165
25 mg
$350.00
7
(0)

Dantrolene interferes with calcium release from the sarcoplasmic reticulum, potentially impacting CAMTA1 indirectly.

Bepridil

64706-54-3sc-507400
100 mg
$1620.00
(0)

Bepridil is a calcium channel blocker with potential indirect effects on CAMTA1 through modulation of calcium signaling.

Felodipine

72509-76-3sc-201483
sc-201483A
10 mg
50 mg
$91.00
$222.00
1
(1)

Felodipine, another calcium channel antagonist, may influence CAMTA1 indirectly by affecting calcium-mediated signaling pathways.

trans Lacidipine

103890-78-4sc-213066
10 mg
$153.00
(0)

Lacidipine, a dihydropyridine calcium channel blocker, might affect CAMTA1 activity indirectly via calcium signaling modulation.